Microdialysis study of bromocriptine and its metabolites in rat pituitary and striatum

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 25, Issue 2, 2000, Pages 79-84

  Granveau Renouf, S ^a   Valente, D ^a   Durocher, A ^a   Grognet, J M ^a   Ezan, E ^a  

^a Institut National de la Recherche Agronomique   (France)

Author keywords

Bromocriptine; Metabolism; Microdialysis; Pituitary; Striatum

Indexed keywords

BROMOCRIPTINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DRUG METABOLITE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CORPUS STRIATUM; DIALYSATE; DISSOCIATION; DRUG BLOOD LEVEL; DRUG PENETRATION; DRUG RECEPTOR BINDING; DRUG TISSUE LEVEL; HYPOPHYSIS; MALE; MICRODIALYSIS; NONHUMAN; RECEPTOR AFFINITY;

ANIMALS; BROMOCRIPTINE; CORPUS STRIATUM; DOPAMINE AGONISTS; MALE; MICRODIALYSIS; PITUITARY GLAND; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2;

EID: 0033710983     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03190071     Document Type: Article

References (34)

1. A broad spectrum of prolactin suppression by bromocriptine in hyperprolactinemic women: A study of serum prolactin and bromocriptine levels after acute and chronic administration of bromocriptine
2. Current drug therapy for Parkinson's disease. A review
3. The pharmacology of Parkinson's disease therapy: An update
4. Increased circulating levels of bromocriptine after vaginal compared with oral administration
5. The motor effect of bromocriptine - A review
6. Distribution and excretion in the rat and monkey of [82Br]bromocriptine
7. High-performance liquid chromatographic assay of bromocriptine in rat plasma and brain
8. Scope and limitations of in vivo brain dialysis: A comparison of its application to various neurotransmitter systems
9. Brain microdialysis
10. Microdialysis - A novel technique for clinical investigations
11. Microdialysis in pharmacokinetics
12. Morphine and morphine metabolites' kinetics in the rat brain as assessed by transcortical microdialysis
13. Measurement and pharmacokinetic analysis of imipramine and its metabolite by brain microdialysis
14. In vivo alterations in the gonadotropin-releasing hormone pulse generator and the secretion and clearance of luteinizing hormone in the uremic castrate rat
15. The rat brain
16. Immunoassay of bromocriptine and specificity of antibody
17. Enzyme immunoassays for bromocriptine and its metabolites
18. Fate and disposition of bromocriptine in animals and man. I: Structure elucidation of the metabolites
19. Fate and disposition of bromocriptine in animals and man. II: Absorption, elimination and metabolism
20. Differences in the pharmacokinetics of cocaine in naive and cocaine-experienced rats
21. Resumption of prolactin secretion after dopaminergic inhibition: Differential effects of dopamine and its agonists
22. A randomised controlled study comparing bromocriptine to which levodopa was later added, with levadopa alone in previously untreated patients with Parkinson's disease: A five year follow up
23. Metabolite involvement in bromocriptine induced circling behaviour in rodents
24. Central dopamine agonistic activity and microsomal biotransformation of lisuride, lergotrile and bromocriptine
25. Metabolite involvement in the behavioral effects in cats
26. Pharmacokinetics and pharmacodynamics of bromocriptine in the rat
27. A comparison between three methods for estimation of extracellular concentrations of exogenous and endogenous compounds by microdialysis
28. The use of an 'internal standard' for control of the recovery in microdialysis
29. In vivo calibration of microdialysis probes for exogenous compounds
30. Pharmacokinetic measurements of drugs in lung epithelial lining fluid by microdialysis: Aminoglycoside antibiotics in rat bronchi
31. Effects of castration on LH-RH patterns in intrahypophysial microdialysates
32. Differential effect of systemic administration of bromocriptine and L-DOPA on the release of acetylcholine from striatum of intact and 6-OHDA-treated rats
33. Low and high dose bromocriptine have different effects on striatal dopamine release: An in vivo study